Global Genotyping Assay Market By Overview
Introduction:
Genotyping Assay Market was valued at US$ 18.5 Billion in 2024 and is projected to grow at a CAGR of 35.40% to reach US$ 291.6 Billion by 2034.
Genotyping is a technology that compares an individual's genomic sequence or allelic genes to a reference sequence to identify genetic differences. Genotyping helps detect genetic variants including structural changes in DNA and single nucleotide polymorphisms. The goal of genotyping is to discriminate between sequences rather than measuring the level of a particular DNA sequence. If a scatter plot could show the path taken by each data point during the experiment, it would look like a clam shell. Genotyping PCR is used to determine the genotype of an organism PCR primers are specifically designed to amplify a portion of the transgene (in a transgenic animal) or a mutation (in a mutant animal). Genotyping is the process of examining an individual's DNA sequence. Genetic variations can be examined through biological testing and compared, compared to the development of other people. Genetic anomalies such as single nucleotide polymorphisms and major structural changes in DNA can be studied using genotyping. Genotyping of microorganisms, such as bacteria and viruses, can help identify a person's parentage. A genotyping assay is a widely used method for determining DNA sequence and genetic makeup by comparing it with other sequences. High efficiency, operational flexibility and access to multiple parameters in a single test are some of the essential features of modern genotyping assays. The increasing severity of acute and infectious diseases has drawn the attention of biotechnology, biopharmaceutical and pharmaceutical companies to the drug discovery and drug development process, thereby driving the Global genotyping assay market. Also the increase in the number of genetic diseases in individuals and increasing prevalence of genetic disorders in the population are the major drivers of the market.
Global Genotyping Assay Market By Dynamics
A factor driving the market on Prakash genotyping is low key costs of the technique, Punjab and DNA sequencing. The technology enables production miniaturization, automation, and overall cost reduction, as well as operational flexibility and inclusion of multipara meter testing. These local, NGS DNA sequencing techniques allow rapid, accurate sequencing for high production efficiency in rural areas. The cost of specialized DNA sequencing is also low, the overall cost of genomic and genotyping is low. Genetic disorders disorder rate, development of genoping for drug development are the key factors of production in the level genotyping assay market. Additionally, discovery and discovery of drug data analysis bioinformatics, the growing popularity of personalized medicine, and increasing awareness of genotyping assays will drive the growth of this target market. Other factors expected to drive the Global genotyping assay market are increasing number of rapid genotyping-based diagnostic tests and growing plant and animal genotyping research activities. However, the high cost of equipment used in genotyping assays may hinder the growth of the Global market in the future. Increasing genotyping and sequencing research and development activities and huge demand for plant and animal genome analysis are expected to create new growth opportunities for the Global genotyping assay market in the coming years.
Technological development
The growth of the genotyping assay market is primarily attributed to increasing demand for personalized medicine, technological advancements in genotyping assay platforms, and increasing prevalence of chronic diseases. Continuous focus and investment by key players in technological development is leading to new product launches with reduced process time and automation. Advanced equipment is easy to operate and helps in analyzing multiple parameter testing. Advanced PCR techniques, sequencing or capillary electrophoresis help provide rapid analysis, accurate sequencing and high efficiency. In October 2022, Single-tablet DAA in a patient with chronic hepatitis C and decompensated liver cirrhosis. This patient was asymptomatic, and transient elastography revealed a fibrosis score of 4.8 kPa, indicating no evidence of fibrosis. Previous health status was good with no chronic use of prescription drugs and no comorbidities including hepatitis B or HIV infection. HCV genotyping assay showed genotype 1b In November 2019 her fibrosis score was 36.9 kPa, indicating cirrhosis.
Global Genotyping Assay Market By Segmentation
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
The genotyping assay market is segmented based on product and service, technology, application, end user, and region.
Genotyping Assay Market, By Product and Service
On the basis of Product and Service, Global Genotyping Assay Market is segmented into Reagents and Kits, Genotyping Services, Instruments, and Bioinformatics. Among, increasing demand for reagents, samples and kits used in the genome sequencing process, the reagents and kits segment witnessed significant growth in 2020. However, it is estimated that the bioinformatics market will witness a profitable growth over the forecast period as a result of increasing demand for better and more advanced systems and solutions in the healthcare and diagnostic industries for storing patient genetic data.
Genotyping Assay Market, By Technology
On the basis of Technology, the Global Genotyping Assay Market is segmented into Microarrays, Sequencing, Capillary Electrophoresis, MALDI-TOF, Others. The market is segmented into microarray, polymerase chain reaction, sequencing, capillary electrophoresis and matrix-assisted laser desorption or ionization-time of flight mass spectrometry. Among these, the sequencing segment is expected to account for the largest revenue share during the forecast period due to ongoing technological advancements in the field of genotyping assays, accessibility to high-speed sequencing, and increasing application of DNA sequencing worldwide.
Genotyping Assay Market, By Application
On the basis of Application, the Global Genotyping Assay Market is segmented into Pharmacogenomics, Diagnostic and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and other. The pharmacogenomics segment accounted for the largest revenue share in 2020 and is expected to register a significant revenue growth rate during the forecast period. This growth is attributed to the growing demand for genotyping in diagnostics and the need to predict drug efficacy. Growing demand for personalized medicine is expected to boost the revenue of the diagnostics and personalized medicine segment during the forecast period.
Genotyping Assay Market, By End User
On the basis of End User, the target market is classified into Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other. The pharmaceutical and biotechnology industries will hold a large share of the market. The segment growth in 2020 is mainly attributed to the growing need for pharmacogenomics in the drug development process and rising demand for specific therapies. The genotyping market is expected to expand significantly over the forecast period, especially in the diagnostic and research institute department. The education institutes segment is expected to register a strong revenue CAGR during the forecast period due to increasing funding provided by the government for research and increasing collaboration between key players and academic institutions for drug development.
Regional Insights:
On region the Global Genotyping Assay Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the North American region is expected to dominate the overall market due to the rising incidence of genetic diseases and immediate measures that are taken accordingly. On the other hand, Europe is also seen to be growing in terms of improved healthcare and medical facilities and hence, the market in Europe and Asia Pacific is expected to grow during the forecast period on account of developing medical infrastructure.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product & Service - Reagents and Kits, Genotyping Services, Instruments, and Bioinformatics By Technology - Microarrays, Sequencing, Capillary Electrophoresis, MALDI-TOF, Others By Application - Pharmacogenomics, Diagnostic and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, and Others By End User - Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at Global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Global Genotyping Assay Market report based on product and service, technology, application, end user, and region:
Genotyping Assay Market, By Product and Services:
- Reagents and Kits
- Genotyping Services
- Instruments
- Bioinformatics
Genotyping Assay Market, By Technology:
- Microarrays
- Sequencing
- Capillary Electrophoresis
- MALDI-TOF
- Others
Genotyping Assay Market, By Application:
- Pharmacogenomics
- Diagnostic and Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Others
Genotyping Assay Market, By End User:
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic and Research Laboratories
- Academic Institutes
- Other
Genotyping Assay Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Genotyping Assay Market By Key Players
The key players operating the Global Genotyping Assay Market includes
- Illumina innovative sequencing and array technologies are making significant advances in life science research, translational and consumer genomics, and molecular diagnostics.
- Thermo Fisher Scientific, Inc. The company, a global leader in providing science services, announced the launch of its Applied Bio systems HIV-1 Genotyping Kit with Integers, a research-use-only assay that screens positive samples of human immunodeficiency virus (HIV) for common resistance genetic variants. Antiretroviral therapeutics.
- F. Hoffmann-La Roche Ltd F is a biotechnology company that develops medicines and diagnostics to treat major diseases. It provides drugs for the treatment of cancer, other auto-immune diseases, central nervous system disorders, eye disorders, infectious diseases and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics and diabetes management solutions.
- Agilent Technologies, Inc. is a leader in the life sciences, diagnostics and applied chemical markets. The company provides equipment, services, consumables, applications and expertise to laboratories around the world, enabling customers to get the insights they seek.
- Danaher The life sciences companies at Danaher Corporation (“Danaher”) make this pioneering scientific research possible in medical research facilities, academic institutions and government agencies. These capabilities extend beyond research with the world's most advanced filtration, separation and purification technologies, which power the manufacture of biopharmaceuticals, microelectronics and more.
- Roche Diagnostics is a division of Roche. They develop and integrate diagnostic solutions that address today's challenges and anticipate tomorrow's needs. In more than 100 countries, they offer the industry's most comprehensive in vitro diagnostics solutions, including molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, point of care testing, patient self-testing, next generation sequencing and laboratory automation and IT, and decision support. Solution.
- GE Healthcare the companies aim to develop new artificial intelligence (AI) powered analytics and workflow solutions to serve both the clinical and biopharma markets.
- Fluidigm Corporation announced the availability of assays and primers optimized for the company's integrated fluidic circuit technology.
- PerkinElmer optimized, automated solutions are designed to improve the efficiency of your genomic workflow. These solutions are designed to address the challenges associated with genomic analysis by providing labs with complete, single source solutions that cover everything from sample to solution.
- Erofins Scientific through its subsidiaries, is a global leader in food, environmental, pharmaceutical and cosmetic product testing, discovery pharmacology, forensics, advanced materials science and agricultural science contract research services.
Global Genotyping Assay Market By Key Issues Addressed
Recent Development:
- In September 2022, the role of circulating tumor DNA in guiding cancer treatment and future applications. In the era of precision medicine, timely cancer genotyping is essential to guide treatment and gather valuable prognostic information. Invasive tissue sampling is the standard method for establishing a cancer diagnosis, but it has limitations. Circulating tumor DNA (ctDNA) refers to cell-free DNA originating from tumors. ctDNA assays are a minimally invasive alternative to tissue-based molecular tests and are already used in the management of many advanced cancer subtypes.
- In May 2022, Technical comparison of human papillomavirus genotyping assays from population-based cervical cancer screening in south central Ethiopia. High-risk human papillomavirus (HPV) is the most important cause of cervical cancer. The highest burden of disease is seen in low- and lower-middle-income countries (LMIC). Several new HPV screening assays have been developed to test for high-risk HPV (hr-HPV). We compared the performance and adequacy of three HPV genotyping assays in population samples of rural women in south-central Ethiopia.
- In February 2021, SOFIVA Genomics announced the launch of Taiwan's first-ever genotyping test for endometrial cancer and aims to expand its precision medicine product line.
Global Genotyping Assay Market By Company Profile
- Illumina*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.
- Danaher
- Roche Diagnostics
- GE Healthcare
- Fluidigm Corporation
- PerkinElmer
- Eurofins Scientific
“*” marked represents similar segmentation in other categories in the respective section
Global Genotyping Assay Market By Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Product and Services
- Key Thickness Insights
- Secondary Data
- Major Secondary Product and Services
- Secondary Product and Services
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product and Service
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Genotyping Assay Market, By Product and Service
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Reagents and Kits
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Genotyping Services
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Instruments
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Bioinformatics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genotyping Assay Market, By Technology
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Microarrays
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Sequencing
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Capillary Electrophoresis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- MALDI-TOF
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genotyping Assay Market, By Application
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Pharmacogenomics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diagnostic and Personalized Medicine
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Agricultural Biotechnology
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Animal Genetics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genotyping Assay Market, By End User, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Pharmaceutical and Biopharmaceutical Companies
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diagnostic and Research Laboratories
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Academic Institutes
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Global Genotyping Assay Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Product and Service, 2022
- Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Product and Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Product and Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Product and Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Product and Service, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Technology, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Application, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End User, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Illumina
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- F. Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Danaher
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Fluidigm Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- PerkinElmer
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Eurofins Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
genotyping assay market is segmented based on product and service, technology, application, end user, and region.
Increasing popularity of personalized medicine and increasing awareness of genotyping assays will drive the growth of this target market. Other factors expected to drive the global genotyping assay market are rapid genotyping-based diagnostic tests and growing number of plant and animal genotyping research activities.
North American region is expected to dominate the overall market due to the rising incidence of genetic diseases and immediate measures that are taken accordingly.
Key players operating in the Global Genotyping Assay Market includes Illumina, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Danaher, Roche Diagnostics, GE Healthcare, Fluidigm Corporation, PerkinElmer, Erofins Scientific.